• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/38

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

38 Cards in this Set

  • Front
  • Back
modified-release dosage form is:
a dosage form having the time course and/or location of the drug release chosen to accomplish therapeutic or convenience objectives not offered by conventional dosage forms
conventional dosage forms:
fast release of the drug at the site of administration
various types of modified- release products:
mainly oral, but also transdermal, intramuscular, subcutaneous
(modified- released products)

extended-release dosage form:
- the release starts immediately, but is slow
- results in at least two-fold reduction in the dosing frequency
(modified- released products)

delayed-release dosage form:
- releases a discrete portion of the dose at a later time, although one portion can be released immediately
(modified- released products)

targeted-release dosage form:
- releases drug at or near the intended physiologic site of action
(extended- released dosage forms)

prolonged-release dosage form
- releases the drug slowly
- provides a drug continuous supply over an extended period
- oral dosing + all other categories
(extended- released dosage forms)

sustained- release dosage form
- delivers an initial (loading) dose immediately

- the loading dose is followed by a slow and constant release
(delayed-release dosage forms)

enteric-coated tablet
- the enteric coating is stable in stomach
- it will dissolve in the higher pH of small intestine
- used for drugs irritating stomach and to increase stability of hydrolyzing drugs
(delayed-release dosage forms)

repeat-release tablet
- the first dose is released immediately
- the second dose is released later
- saves one administration
(targeted-release dosage form)

first-order targeting
drug is delivered to the capillary bed of the site of action
(targeted-release dosage form)

second-order targeting
drug is delivered to the surroundings of a special cell type (eg tumor cells)
(targeted-release dosage form)

third-order targeting
drug is delivered to intracellular space of the target cells
pharmacokinetics of modified release products: drug release

release of the drug can be:
instantaneous (delayed-release)

zero-order process (extended release products, mostly non-oral)

approximately first order process- oral extended-release products
If the release is not immediate, one more compartment is added to the compartment model:
dosage-form compartment
pharmacokinetics of extended-release products I

designed for :
zero- order release (ideal case)
for oral products, zero-order kinetics frequently not achieved in vivo due to irregularities in:
- the stomach (food, change of pH; absorption; agitation

- small intestine (transit time too short: 4-6 hrs

- large intestine (bacteria, lack of water)
pharmacokinetics of extended- release products II

fast absorption eliminates what compartment?
dosing compartment
pharmacokinetics of extended- release products II

fast plasma/tissue equilibriation eliminates what compartment (s)?
tissue compartment and deep tissue compartment
Used compartment models
see pg 2 slide 5
pharmacokinetics of extended- release products II

for fast absorption and fast plasma/tissue distribution, both two-compartment models will be used in:
a similar way as previously for slow absorption
pharmacokinetics of extended- release products II

the rate constant of absorption will be substituted by:
the rate constant of drug release
pharmacokinetics of extended- release products II

there are separate descriptions for the zero-order release and the first-order release
true
zero-order drug release: time of drug release

drug release proceeds at a constant rate until :
the amount of the drug in the dosage form is depleted
zero-order drug release: time of drug release

effective dose is:
Deff= Fr * D (1)
the drug amount available for release
zero-order drug release: time of drug release

what is Kro?
the rate at which the effective dose is released
zero-order drug release: time of drug release

the time of release is (equation)?
Fr * D (2)
tr= ---------------
Kro * Vd
zero-order drug release: time course of plasma concentration

there are 2 phases:
release phase

elimination phase
zero-order drug release: time course of plasma concentration

release phase:
cp --> increasing

cp(t)= Kro/ke * (1-e^-ke*t)
zero-order drug release: time course of plasma concentration

the elimination phase:
t=tr
cp --> decreasing

cp(t)= cp(tr) * e^-ke*t
zero-order drug release: time course of plasma concentration

the elimination phase:
starts at time of administration:
cp--> decreasing

cp(t)= cp(tr) * e^-ke * (t-tr)
zero-order release: plasma concentration- time profile II

the rate at which the (ss) is achieved depends on the :
elimination rate constant, ke
zero-order release: plasma concentration- time profile II

the duration (length) of the plateau level depends on:
the dose, D
zero-order release: plasma concentration- time profile II

during the plateau level, in plasma- rate of release =
rate of elimination
at the plateau level, the two rates are equal

equation:
Kro= ke * cp(ss)
first order drug release: models and descriptions:
kr
dosage form compartment ----> central compartment---->
ke
first-order drug release: time course of the plasma concentration

fast absorption and fast plasma/tissue equilibrium is assumed
true
what is peak time?
the time when the maximum plasma concentration is achieved